INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 135 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,172 | -30.4% | 90,416 | -20.1% | 0.00% | -100.0% |
| Q2 2023 | $50,538 | +43.6% | 113,188 | +401.8% | 0.00% | 0.0% |
| Q4 2022 | $35,189 | -59.6% | 22,557 | -54.9% | 0.00% | -66.7% |
| Q2 2022 | $87,000 | -9.4% | 50,060 | +87.1% | 0.00% | 0.0% |
| Q1 2022 | $96,000 | -39.6% | 26,756 | +55.8% | 0.00% | -66.7% |
| Q1 2021 | $159,000 | – | 17,170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |